The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Embolization Particle Market Research Report 2025
Synopsis
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global Embolization Particle market was valued at US$ 2012.7 million in 2023 and is anticipated to reach US$ 5248.9 million by 2030, witnessing a CAGR of 14.5% during the forecast period 2024-2030.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle.
Report Scope
The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolization Particle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolization Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolization Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global Embolization Particle market was valued at US$ 2012.7 million in 2023 and is anticipated to reach US$ 5248.9 million by 2030, witnessing a CAGR of 14.5% during the forecast period 2024-2030.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle.
Report Scope
The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolization Particle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolization Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolization Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Embolization Particle Market Overview
1.1 Product Overview and Scope of Embolization Particle
1.2 Embolization Particle Segment by Type
1.2.1 Global Embolization Particle Market Value Comparison by Type (2024-2030)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Segment by Application
1.3.1 Global Embolization Particle Market Value by Application: (2024-2030)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Global Embolization Particle Market Size Estimates and Forecasts
1.4.1 Global Embolization Particle Revenue 2019-2030
1.4.2 Global Embolization Particle Sales 2019-2030
1.4.3 Global Embolization Particle Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Embolization Particle Market Competition by Manufacturers
2.1 Global Embolization Particle Sales Market Share by Manufacturers (2019-2024)
2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Embolization Particle Average Price by Manufacturers (2019-2024)
2.4 Global Embolization Particle Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Embolization Particle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Embolization Particle, Product Type & Application
2.7 Embolization Particle Market Competitive Situation and Trends
2.7.1 Embolization Particle Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Embolization Particle Players Market Share by Revenue
2.7.3 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Embolization Particle Retrospective Market Scenario by Region
3.1 Global Embolization Particle Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Embolization Particle Global Embolization Particle Sales by Region: 2019-2030
3.2.1 Global Embolization Particle Sales by Region: 2019-2024
3.2.2 Global Embolization Particle Sales by Region: 2025-2030
3.3 Global Embolization Particle Global Embolization Particle Revenue by Region: 2019-2030
3.3.1 Global Embolization Particle Revenue by Region: 2019-2024
3.3.2 Global Embolization Particle Revenue by Region: 2025-2030
3.4 North America Embolization Particle Market Facts & Figures by Country
3.4.1 North America Embolization Particle Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Embolization Particle Sales by Country (2019-2030)
3.4.3 North America Embolization Particle Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolization Particle Market Facts & Figures by Country
3.5.1 Europe Embolization Particle Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Embolization Particle Sales by Country (2019-2030)
3.5.3 Europe Embolization Particle Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolization Particle Market Facts & Figures by Country
3.6.1 Asia Pacific Embolization Particle Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Embolization Particle Sales by Country (2019-2030)
3.6.3 Asia Pacific Embolization Particle Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolization Particle Market Facts & Figures by Country
3.7.1 Latin America Embolization Particle Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Embolization Particle Sales by Country (2019-2030)
3.7.3 Latin America Embolization Particle Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolization Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolization Particle Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Embolization Particle Sales by Country (2019-2030)
3.8.3 Middle East and Africa Embolization Particle Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolization Particle Sales by Type (2019-2030)
4.1.1 Global Embolization Particle Sales by Type (2019-2024)
4.1.2 Global Embolization Particle Sales by Type (2025-2030)
4.1.3 Global Embolization Particle Sales Market Share by Type (2019-2030)
4.2 Global Embolization Particle Revenue by Type (2019-2030)
4.2.1 Global Embolization Particle Revenue by Type (2019-2024)
4.2.2 Global Embolization Particle Revenue by Type (2025-2030)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2019-2030)
4.3 Global Embolization Particle Price by Type (2019-2030)
5 Segment by Application
5.1 Global Embolization Particle Sales by Application (2019-2030)
5.1.1 Global Embolization Particle Sales by Application (2019-2024)
5.1.2 Global Embolization Particle Sales by Application (2025-2030)
5.1.3 Global Embolization Particle Sales Market Share by Application (2019-2030)
5.2 Global Embolization Particle Revenue by Application (2019-2030)
5.2.1 Global Embolization Particle Revenue by Application (2019-2024)
5.2.2 Global Embolization Particle Revenue by Application (2025-2030)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2019-2030)
5.3 Global Embolization Particle Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Corporation Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sirtex Medical Embolization Particle Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Corporation Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merit Medical Embolization Particle Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Corporation Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cook Medical Embolization Particle Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Corporation Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTG Medical Embolization Particle Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Corporation Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Corporation Embolization Particle Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.6.1 HENGRUI Medical Corporation Information
6.6.2 HENGRUI Medical Description and Business Overview
6.6.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HENGRUI Medical Embolization Particle Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials B.V.
6.8.1 INterface BIOmaterials B.V. Corporation Information
6.8.2 INterface BIOmaterials B.V. Description and Business Overview
6.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
6.8.5 INterface BIOmaterials B.V. Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Corporation Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alicon Embolization Particle Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolization Particle Industry Chain Analysis
7.2 Embolization Particle Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolization Particle Production Mode & Process
7.4 Embolization Particle Sales and Marketing
7.4.1 Embolization Particle Sales Channels
7.4.2 Embolization Particle Distributors
7.5 Embolization Particle Customers
8 Embolization Particle Market Dynamics
8.1 Embolization Particle Industry Trends
8.2 Embolization Particle Market Drivers
8.3 Embolization Particle Market Challenges
8.4 Embolization Particle Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
